Member Info for Nolupus

Dallo,

I agree, if we are talking about "assets" but cash in the bank is another story....I maintain my estimate of 6 million in CASH...

Dallo,

Good post...but i will nit pick on the cah position....end of june ...net "assets" of 9 million.....You will need to take off the 2 million investment in Incanthera + 3 months operating expenses + r+d costs....My estimate is cah position of between 5.5 million and 6 million...but whatever...

@halfbutt

The bitter pill ? Just the truth, imho...There are always two sides to a coin and as you say people need to dream when they invest so they always tend to see what they wish to see and not always the reality...

But

I don't expect to see IMM at 5p or even at 10p.....I think we are after hitting the bottom or near enough to it at this stage...imo....but everyone to their own point of view...only time will tell

BOL

Mr "strong buy " Frits, at 1.40 at 50p at 30p at 20p is now at "no opinion " ....

A medal is better than abuse....

11.40...Now

R de renard....Did i say 11.50 was coming ?

at 11.55p today...and some people say....it's getting busy ??

Am i missing something ?

@saxonaxe,

A smart investor will analyse both sides of the coin, instead of just seeing the most optimistic outcome possible ...imv

but everyone to their own point of view...

@saxonaxe,

The outcome of the Map is in two years time...

A P3 trial takes longer ....

Remind me again when does the P140 patent run out ?

On the upside, IF the FDA allows changes to the endpoints in lupus trials, this just might get a partner to sign up with IMM to do another P3....( and they won't wait for the Map program to finish imv )

DYOR

The FDA will allow for new endpoints to be used in lupus clinical trials, imo but that means that IMM will have to do another P3 trial....catch22

Trombone, the market is always right...until it's proven wrong ;-)

Over done or not...The market is always right....

Timing is everything and No news on lupuzor due for a long time

Retour du renard... The market is pricing in the cash burn as well as the "company's communication skills" imo...

Time is money...and Lupuzor is awaiting the FDA ...

With approx 7 million in the bank..... Is the market wrong, retour du renard ??

Good interview by Tim

He seems to be waiting for the FDA to change their criteria on Lupus trials and their endpoints...I also think that this will happen due to the intense lobbying by Lupus specialists.....Next year, hopefully...

@retour du renard

I am off to sunny Spain for a weeks hols....left an order at 11.5p.....let's see if i miss the boat or not....

Ok Reour du renard

So why did they tell the market about appointing Bryan Garnier ?

@saxonaxe

Not to satisfy me...but the market..

I don't think that ii should have to email Lisa to get an answer...This information should be made public.. imv

@retour the renard

The appointment of Bryan Garnier was announced via a RNS so why not announce their departure via RNS ??

The market should be informed in the appropriate manner, imv

@stockraiser
As you point out yourself was appointed " to support the Company as we progress towards commercialisation."

Does this mean that IMM will not now be progressing towards commercialisation ??

Does this mean that IMM does'nt need any longer "pan European broking capabilities " ? What about Ureka :-)

Bryan Garnier are "deal makers" and therefore if they are no longer working for IMM, i would suggest that IMM should release a RNS to inform the market !!